{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:12:54Z","timestamp":1783091574378,"version":"3.54.6"},"reference-count":87,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.mce.2011.09.019","type":"journal-article","created":{"date-parts":[[2011,9,16]],"date-time":"2011-09-16T19:30:26Z","timestamp":1316201426000},"page":"60-70","source":"Crossref","is-referenced-by-count":43,"title":["Multiple nuclear receptor signaling pathways mediate the actions of synthetic progestins in target cells"],"prefix":"10.1016","volume":"357","author":[{"given":"Nicole L.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa E.","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne D.","family":"Tilley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2011.09.019_b0005","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.steroids.2011.03.001","article-title":"Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception","volume":"76","author":"Africander","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.mce.2011.09.019_b0010","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1095\/biolreprod66.2.297","article-title":"Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome","volume":"66","author":"Apparao","year":"2002","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.mce.2011.09.019_b0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0303-7207(99)00109-4","article-title":"Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells","volume":"154","author":"Bentel","year":"1999","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.mce.2011.09.019_b0020","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.mce.2011.09.019_b0025","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1096\/fj.06-7518com","article-title":"Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer","volume":"21","author":"Birrell","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.mce.2011.09.019_b0030","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1200\/JCO.1995.13.7.1572","article-title":"Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression","volume":"13","author":"Birrell","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mce.2011.09.019_b0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0960-0760(95)00156-T","article-title":"Lack of estrogenic potential of progesterone- or 19-nor-progesterone-derived progestins as opposed to testosterone or 19-nor-testosterone derivatives on endometrial Ishikawa cells","volume":"55","author":"Botella","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2011.09.019_b0040","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jsbmb.2005.06.032","article-title":"Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells","volume":"97","author":"Bray","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2011.09.019_b0045","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/BF01734339","article-title":"Inhibition of androgen receptor binding by natural and synthetic steroids in cultured human genital skin fibroblasts","volume":"64","author":"Breiner","year":"1986","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.mce.2011.09.019_b0050","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-2005-864035","article-title":"Progesterone receptor antagonists and the endometrial antiproliferative effect","volume":"23","author":"Brenner","year":"2005","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.mce.2011.09.019_b0055","doi-asserted-by":"crossref","first-page":"8487","DOI":"10.1158\/0008-5472.CAN-04-3077","article-title":"Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate","volume":"65","author":"Buchanan","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2011.09.019_b0060","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/PAI.0b013e3181c10180","article-title":"Estrogen receptor, progesterone receptor, and glucocorticoid receptor expression in normal breast tissue, breast in situ carcinoma, and invasive breast cancer","volume":"18","author":"Buxant","year":"2010","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.mce.2011.09.019_b0065","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/bjc.1993.175","article-title":"Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism","volume":"67","author":"Catherino","year":"1993","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mce.2011.09.019_b0070","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/jama.2010.1500","article-title":"Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women","volume":"304","author":"Chlebowski","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.mce.2011.09.019_b0075","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women\u2019s Health Initiative Randomized Trial","volume":"289","author":"Chlebowski","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.mce.2011.09.019_b0080","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1056\/NEJMoa0807684","article-title":"Breast cancer after use of estrogen plus progestin in postmenopausal women","volume":"360","author":"Chlebowski","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2011.09.019_b0085","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/humupd\/dmq022","article-title":"Hormonal contraception and risk of cancer","volume":"16","author":"Cibula","year":"2010","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.mce.2011.09.019_b0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0002-9378(96)70379-4","article-title":"Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques","volume":"174","author":"Cline","year":"1996","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mce.2011.09.019_b0095","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1210\/en.2008-0356","article-title":"The androgen and progesterone receptors regulate distinct gene networks and cellular functions in decidualizing endometrium","volume":"149","author":"Cloke","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2011.09.019_b0100","doi-asserted-by":"crossref","unstructured":"Courtin, A., Communal, L., Vilasco, M., Cimino, D., Mourra, N., de, B.M., Taverna, D., Faussat, A.M., Chaouat, M., Forgez, P., Gompel, A., 2011. Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells. Breast Cancer Res. Treat., in press.","DOI":"10.1007\/s10549-011-1394-5"},{"key":"10.1016\/j.mce.2011.09.019_b0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1210\/en.132.1.179","article-title":"Androgen receptor-mediated stimulation of 17 beta-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75\u20131 human breast cancer cells","volume":"132","author":"Couture","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2011.09.019_b0110","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1210\/me.2009-0310","article-title":"The rules of DNA recognition by the androgen receptor","volume":"24","author":"Denayer","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2011.09.019_b0115","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/1471-2407-6-246","article-title":"Effects of estradiol and medroxyprogesterone acetate on morphology, proliferation and apoptosis of human breast tissue in organ cultures","volume":"6","author":"Eigeliene","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.mce.2011.09.019_b0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-007-9523-x","article-title":"Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study","volume":"107","author":"Fournier","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.mce.2011.09.019_b0125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1006\/taap.1996.8069","article-title":"Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay","volume":"143","author":"Gaido","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.mce.2011.09.019_b0130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0960-0760(02)00192-9","article-title":"The intrinsic transcriptional estrogenic activity of a non-phenolic derivative of levonorgestrel is mediated via the estrogen receptor-alpha","volume":"82","author":"Garcia-Becerra","year":"2002","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2011.09.019_b0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jsbmb.2004.02.003","article-title":"Comparative evaluation of androgen and progesterone receptor transcription selectivity indices of 19-nortestosterone-derived progestins","volume":"91","author":"Garcia-Becerra","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2011.09.019_b0140","doi-asserted-by":"crossref","first-page":"R1036","DOI":"10.1186\/bcr1340","article-title":"The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells","volume":"7","author":"Ghatge","year":"2005","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.mce.2011.09.019_b0145","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1177\/1933719108323446","article-title":"The activity of medroxyprogesterone acetate, an androgenic ligand, in ovarian cancer cell invasion","volume":"15","author":"Gogoi","year":"2008","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.mce.2011.09.019_b0150","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1210\/er.18.4.502","article-title":"Physiological action of progesterone in target tissues","volume":"18","author":"Graham","year":"1997","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.mce.2011.09.019_b0155","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ijc.2910570121","article-title":"Androgen responsiveness of the new human endometrial cancer cell line MFE-296","volume":"57","author":"Hackenberg","year":"1994","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.mce.2011.09.019_b0160","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00689836","article-title":"Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor","volume":"25","author":"Hackenberg","year":"1993","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.mce.2011.09.019_b0165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3181\/00379727-83-20301","article-title":"Myotrophic activity of 19-nortestosterone and other steroids determined by modified levator ani muscle method","volume":"83","author":"Hershberger","year":"1953","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.mce.2011.09.019_b0170","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1477-7827-1-73","article-title":"Estrogen, progesterone and epithelial ovarian cancer","volume":"1","author":"Ho","year":"2003","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.mce.2011.09.019_b0175","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1210\/jc.84.12.4559","article-title":"Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast","volume":"84","author":"Hofseth","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.09.019_b0180","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/oxfordjournals.humrep.a137595","article-title":"Immunohistochemical localization of androgen receptor in the human endometrium, decidua, placenta and pathological conditions of the endometrium","volume":"7","author":"Horie","year":"1992","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.mce.2011.09.019_b0185","doi-asserted-by":"crossref","first-page":"29821","DOI":"10.1074\/jbc.272.47.29821","article-title":"Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators","volume":"272","author":"Ikonen","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2011.09.019_b0190","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/ijc.10394","article-title":"Expression of androgen receptor and 5alpha-reductases in the human normal endometrium and its disorders","volume":"99","author":"Ito","year":"2002","journal-title":"Int. J. Cancer."},{"key":"10.1016\/j.mce.2011.09.019_b0195","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1210\/me.13.3.440","article-title":"Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone","volume":"13","author":"Kemppainen","year":"1999","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.mce.2011.09.019_b0200","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1200\/JCO.2003.05.151","article-title":"Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population","volume":"21","author":"Kerlikowske","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.mce.2011.09.019_b0205","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/0006-2952(83)90474-4","article-title":"Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes","volume":"32","author":"Kontula","year":"1983","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mce.2011.09.019_b0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2005.07.001","article-title":"Synthetic progestins used in HRT have different glucocorticoid agonist properties","volume":"242","author":"Koubovec","year":"2005","journal-title":"Mol. Cell Endocrinol."},{"issue":"Suppl. 1","key":"10.1016\/j.mce.2011.09.019_b0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13697130500148875","article-title":"Pharmacology of estrogens and progestogens: influence of different routes of administration","volume":"8","author":"Kuhl","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.mce.2011.09.019_b0220","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0039-128X(00)00119-7","article-title":"Nestorone: a progestin with a unique pharmacological profile","volume":"65","author":"Kumar","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.mce.2011.09.019_b0225","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1210\/en.142.9.3791","article-title":"A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonists for ER alpha","volume":"142","author":"Larrea","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2011.09.019_b0230","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/path.1982","article-title":"Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms","volume":"209","author":"Lien","year":"2006","journal-title":"J. Pathol."},{"key":"10.1016\/j.mce.2011.09.019_b0235","first-page":"459","article-title":"Progestogens with antimineralocorticoid activity","volume":"35","author":"Losert","year":"1985","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.mce.2011.09.019_b0240","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0960-0760(00)00127-8","article-title":"Characterization of androgen receptors in a well-differentiated endometrial adenocarcinoma cell line (Ishikawa)","volume":"74","author":"Lovely","year":"2000","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2011.09.019_b0245","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/cmt.4.1.42.48","article-title":"Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens","volume":"4","author":"Lundstrom","year":"2001","journal-title":"Climacteric"},{"key":"10.1016\/j.mce.2011.09.019_b0250","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0022-4731(88)90295-6","article-title":"Androgenic activity of synthetic progestins and spironolactone in androgen-sensitive mouse mammary carcinoma (Shionogi) cells in culture","volume":"31","author":"Luthy","year":"1988","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.mce.2011.09.019_b0255","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/bjc.1991.94","article-title":"Medroxyprogesterone acetate (MPA) in advanced granulosa cell tumours of the ovary\u2013a new therapeutic approach?","volume":"63","author":"Malik","year":"1991","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.mce.2011.09.019_b0260","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0960-0760(94)90254-2","article-title":"Estrogenic and progestagenic activities coexisting in steroidal drugs: quantitative evaluation by in vitro bioassays with human cells","volume":"48","author":"Markiewicz","year":"1994","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2011.09.019_b0265","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1113\/jphysiol.1934.sp003217","article-title":"The assay of progestin","volume":"83","author":"McPhail","year":"1934","journal-title":"J. Physiol."},{"key":"10.1016\/j.mce.2011.09.019_b0270","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jsbmb.2007.10.008","article-title":"Structure-activity relationships of synthetic progestins in a yeast-based in vitro androgen bioassay","volume":"110","author":"McRobb","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2011.09.019_b0275","first-page":"293","article-title":"Antiandrogens: a summary review of pharmacodynamic properties and tolerability in prostate cancer therapy","volume":"71","author":"Migliari","year":"1999","journal-title":"Arch. Ital. Urol. Androl."},{"key":"10.1016\/j.mce.2011.09.019_b0280","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0955-0674(98)80015-X","article-title":"The nuclear receptor ligand-binding domain: structure and function","volume":"10","author":"Moras","year":"1998","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.mce.2011.09.019_b0285","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.steroids.2011.02.002","article-title":"Nomegestrol acetate, a novel progestogen for oral contraception","volume":"76","author":"Mueck","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.mce.2011.09.019_b0290","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1749-6632.1995.tb31386.x","article-title":"Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity","volume":"761","author":"Muhn","year":"1995","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.mce.2011.09.019_b0295","first-page":"3763","article-title":"Dexamethasone and medroxyprogesterone acetate elevate Nm23\u2013H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds","volume":"9","author":"Ouatas","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mce.2011.09.019_b0300","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.maturitas.2006.07.009","article-title":"Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism","volume":"55","author":"Palacios","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.mce.2011.09.019_b0305","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/jnci\/dji111","article-title":"Medroxyprogesterone acetate elevation of Nm23\u2013H1 metastasis suppressor expression in hormone receptor-negative breast cancer","volume":"97","author":"Palmieri","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.mce.2011.09.019_b0310","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/0022-4731(83)90350-3","article-title":"Interaction of medroxyprogesterone acetate with cytosol androgen receptors in the rat hypothalamus and pituitary","volume":"19","author":"Perez-Palacios","year":"1983","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.mce.2011.09.019_b0315","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3109\/09513599909167574","article-title":"The pharmacological profile of a novel norpregnance progestin (trimegestone)","volume":"13","author":"Philibert","year":"1999","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.mce.2011.09.019_b0320","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF01806528","article-title":"Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75\u20131 human breast cancer cells","volume":"13","author":"Poulin","year":"1989","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.mce.2011.09.019_b0325","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF01806369","article-title":"Multiple actions of synthetic \u2018progestins\u2019 on the growth of ZR-75\u20131 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids","volume":"17","author":"Poulin","year":"1991","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.mce.2011.09.019_b0330","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/aje\/kwn044","article-title":"Estrogen plus progestin therapy and breast cancer in recently postmenopausal women","volume":"167","author":"Prentice","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.mce.2011.09.019_b0335","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0022-4731(87)90095-1","article-title":"Medroxyprogesterone acetate: receptor binding and correlated effects on steroidogenesis in rat granulosa cells","volume":"26","author":"Pridjian","year":"1987","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.mce.2011.09.019_b0340","first-page":"3868","article-title":"New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP","volume":"54","author":"Sartorius","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2011.09.019_b0345","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.steroids.2007.10.003","article-title":"Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile","volume":"73","author":"Sasagawa","year":"2008","journal-title":"Steroids"},{"key":"10.1016\/j.mce.2011.09.019_b0350","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/172460089501000109","article-title":"Progesterone agonists and antagonists induce down- and up-regulation of estrogen receptors and estrogen inducible genes in human breast cancer cell lines","volume":"10","author":"Savoldi","year":"1995","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.mce.2011.09.019_b0355","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.maturitas.2003.09.014","article-title":"Classification and pharmacology of progestins","volume":"46","author":"Schindler","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.mce.2011.09.019_b0360","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000226601","article-title":"Comparative effects of chlormadinone acetate and its 3alpha- and 3beta-hydroxy metabolites on progesterone, androgen and glucocorticoid receptors","volume":"84","author":"Schneider","year":"2009","journal-title":"Pharmacology"},{"key":"10.1016\/j.mce.2011.09.019_b0365","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0960-0760(95)00215-4","article-title":"Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines","volume":"55","author":"Schoonen","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol"},{"key":"10.1016\/j.mce.2011.09.019_b0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2004.11.004","article-title":"Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells","volume":"93","author":"Shields-Botella","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2011.09.019_b0375","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jsbmb.2003.08.003","article-title":"An overview of nomegestrol acetate selective receptor binding and lack of estrogenic action on hormone-dependent cancer cells","volume":"87","author":"Shields-Botella","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2011.09.019_b0380","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2165\/00002512-200421130-00004","article-title":"New progestogens: a review of their effects in perimenopausal and postmenopausal women","volume":"21","author":"Sitruk-Ware","year":"2004","journal-title":"Drugs Aging"},{"key":"10.1016\/j.mce.2011.09.019_b0385","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.maturitas.2004.01.001","article-title":"Pharmacological profile of progestins","volume":"47","author":"Sitruk-Ware","year":"2004","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.mce.2011.09.019_b0390","first-page":"21","article-title":"Hormone therapy and the cardiovascular system: the critical role of progestins","volume":"6","author":"Sitruk-Ware","year":"2003","journal-title":"Climacteric"},{"key":"10.1016\/j.mce.2011.09.019_b0395","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1210\/jc.2010-0536","article-title":"Update in hormone therapy use in menopause","volume":"96","author":"Taylor","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.09.019_b0400","doi-asserted-by":"crossref","first-page":"90919","DOI":"10.1016\/0039-128X(74)90063-4","article-title":"Affinities of progestogen and estrogen receptors in rabbit uterus for synthetic progestogens","volume":"23","author":"Terenius","year":"1974","journal-title":"Steroids"},{"key":"10.1016\/j.mce.2011.09.019_b0405","first-page":"2557","article-title":"Estrogen, androgen, glucocorticoid, and progesterone receptors in progestin-induced regression of human breast cancer","volume":"40","author":"Teulings","year":"1980","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2011.09.019_b0410","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00042192-200310020-00003","article-title":"Role of progestogen in hormone therapy for postmenopausal women: position statement of The North American Menopause Society","volume":"10","year":"2003","journal-title":"Menopause"},{"key":"10.1016\/j.mce.2011.09.019_b0415","first-page":"231","article-title":"Endocrinological studies with desogestrel","volume":"33","author":"van der Vies","year":"1983","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.mce.2011.09.019_b0420","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1530\/acta.0.0920560","article-title":"Interaction of synthetic progestagens with renal mineralocorticoid receptors","volume":"92","author":"Wambach","year":"1979","journal-title":"Acta Endocrinol. (Copenh)."},{"key":"10.1016\/j.mce.2011.09.019_b0425","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tem.2011.01.005","article-title":"Progesterone: the ultimate endometrial tumor suppressor","volume":"22","author":"Yang","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.mce.2011.09.019_b0430","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ygyno.2005.06.018","article-title":"Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer","volume":"99","author":"Yang","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.mce.2011.09.019_b0435","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00441-002-0683-z","article-title":"An in vitro long-term culture model for normal human mammary gland: expression and regulation of steroid receptors","volume":"311","author":"Zhuang","year":"2003","journal-title":"Cell Tissue Res."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720711005533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720711005533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T02:57:55Z","timestamp":1592967475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720711005533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":87,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0303720711005533"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2011.09.019","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}